Dr. Yeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
207 S Santa Anita St
Suite P-05
San Gabriel, CA 91776
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1996 - 1999
- SUNY Upstate Medical UniversityClass of 1996
Certifications & Licensure
- CA State Medical License 2001 - 2025
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 35 citationsClinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidSaroj Vadhan-Raj, R. von Moos, Lesley Fallowfield, Donald L. Patrick, François Goldwasser
Annals of Oncology. 2012-12-01 - 116 citationsDelaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients ...David H. Henry, Saroj Vadhan-Raj, Vera Hirsh, Roger von Moos, Vania Hungria
Supportive Care in Cancer. 2014-03-01 - 841 citationsRandomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate ...David H. Henry, Luis Costa, François Goldwasser, Vera Hirsh, Vania Hungria
Journal of Clinical Oncology. 2011-03-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: